SiteOne Therapeutics' Series B Round

SiteOne Therapeutics raised a round of funding on January 06, 2017.

SiteOne Therapeutics, headquartered in Bozeman, Montana, was founded with technology invented at Stanford University that represents a potential advancement in the treatment of acute and chronic pain.…

Articles about SiteOne Therapeutics' Series B Round: